Hyderabad: The Drugs Controller General of India (DCGI) has granted restricted emergency use authorization to Bharat Biotech's COVID vaccine, Covaxin, for children aged 6 to 12. Health Minister Dr Mansukh Mandaviya tweeted on Tuesday that the DCGI has also approved Corbevax emergency use authorization for children aged 5 to 12.
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.
WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s Covid-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.
WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.